0001104659-20-005586.txt : 20200221 0001104659-20-005586.hdr.sgml : 20200221 20200121165616 ACCESSION NUMBER: 0001104659-20-005586 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Therapeutics Inc. CENTRAL INDEX KEY: 0001697532 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-220-9319 MAIL ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 CORRESP 1 filename1.htm

 

Goldman Sachs & Co. LLC

Cowen and Company, LLC

UBS Securities LLC

 

As representatives of the

several underwriters listed

in Schedule I of the Underwriting Agreement

 

c/o Goldman Sachs & Co. LLC

200 West Street

New York, New York 10282

 

c/o Cowen and Company, LLC
599 Lexington Avenue
New York, New York 10022

 

c/o UBS Securities LLC
1285 Avenue of the Americas
New York, New York 10019

 

January 21, 2020

 

VIA EDGAR

Jeffrey Gabor

Office of Life Sciences

Division of Corporation Finance

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

RE:                          Applied Therapeutics, Inc.

Registration Statement on Form S-1 (File No. 333-235988)

Request for Acceleration of Effective Date

 

Mr. Gabor:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Applied Therapeutics, Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 p.m., Eastern Time, on January 23, 2020, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Skadden, Arps, Slate, Meagher & Flom LLP, request by telephone that such Registration Statement be declared effective.

 

Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably

 

 

anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 

We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

 

 

Very truly yours,

 

 

 

GOLDMAN SACHS & CO. LLC

 

COWEN AND COMPANY, LLC

 

UBS SECURITIES LLC

 

 

 

As representatives of the several underwriters listed in Schedule I to the Underwriting Agreement

 

 

 

GOLDMAN SACHS & CO. LLC

 

 

 

By:

/s/ Kristen Grippi

 

 

Name: Kristen Grippi

 

 

Title: Managing Director

 

 

 

COWEN AND COMPANY, LLC

 

 

 

By:

/s/ Bill Follis

 

 

Name: Bill Follis

 

 

Title: Managing Director

 

 

 

UBS SECURITIES LLC

 

 

 

By:

/s/ James Stahlke

 

 

Name: James Stahlke

 

 

Title: Associate Director

 

 

 

By:

/s/ Robin Tang

 

 

Name: Robin Tang

 

 

Title: Director

 

[Signature Page to Underwriters’ Acceleration Request]